Trials / Completed
CompletedNCT01786460
Brain Injury Biomarkers in the General Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (actual)
- Sponsor
- Banyan Biomarkers, Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to use an investigational assay to assess levels of putative biomarkers of traumatic brain injury (TBI) in a general population. The data will be used in a correlative analysis with data collected under a separate study of severe TBI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood draw at Days 0, 7, 14, and 21 |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2013-02-08
- Last updated
- 2017-01-31
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01786460. Inclusion in this directory is not an endorsement.